Keros Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2019 | 63.4% | 63.4% | -112.6% |
| FY2020 | -17.3% | -17.3% | -16.8% |
| FY2021 | -24.2% | -24.2% | -23.0% |
| FY2022 | -37.7% | -37.7% | -34.1% |
| FY2023 | -46.1% | -46.1% | -41.3% |
| FY2024 | -32.8% | -32.8% | -30.4% |
| FY2025 | 28.7% | 28.7% | 25.7% |